Serum level of sCD30 molecule but not sCD30L in patients with psoriasis is reduced by Goeckerman's therapy

Int J Dermatol. 2011 Aug;50(8):1033-5. doi: 10.1111/j.1365-4632.2009.04447.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • CD30 Ligand / blood*
  • Coal Tar / therapeutic use*
  • Female
  • Humans
  • Keratolytic Agents / therapeutic use
  • Ki-1 Antigen / blood*
  • Male
  • Middle Aged
  • Psoriasis* / blood
  • Psoriasis* / drug therapy
  • Psoriasis* / radiotherapy
  • Ultraviolet Therapy / methods*
  • Young Adult

Substances

  • CD30 Ligand
  • Keratolytic Agents
  • Ki-1 Antigen
  • TNFSF8 protein, human
  • Coal Tar